A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we describe in detail methods for extracting macrophages from the bone marrow, spleen, and infarcted heart, and subsequently assessing metabolic flux in live cells.
Metabolic reprogramming is a hallmark of monocyte/macrophage activation and polarization between pro- and anti-inflammatory states. For example, pro-inflammatory (i.e., M1-like) monocytes/macrophages display more reliance on anaerobic glycolysis and less reliance on mitochondrial oxidative phosphorylation, whereas anti-inflammatory (M2-like) macrophages display more reliance on glucose and fatty acid oxidation in the mitochondria. Here, we describe in-depth protocols for extracting macrophages from the two major monocyte/macrophage reservoirs in the body, the spleen and bone marrow, as well as injured tissues such as the heart following myocardial infarction.
Macrophages or monocytes are extracted by immunomagnetic sorting by using antibody-tagged microbeads, which easily bind to cells without compromising their phenotypes. The extracted cells are then cultured in 96-well plates, followed by extracellular flux analysis using a metabolic flux analyzer. Both glycolysis and mitochondrial oxidative phosphorylation can be measured simultaneously in small numbers of cells (as little as 2-3 × 105 cells). This method can easily be performed in 1 day and produces reliable and repeatable results. Ultimately, these methods help to enhance our understanding of metabolic changes during immune and inflammatory responses to injury and disease, which could lead to the development of novel therapeutic targets for immunometabolic pathways.
Immunometabolism is a blossoming field that studies the role of metabolic reprogramming in immune cells across different pathological disease and injury states. Macrophages are a key part of the innate immune system that play critical roles in inflammation, response to infection, antigen presentation, and wound healing1. Understanding how macrophages polarize between pro- and anti-inflammatory (M1-like and M2-like) subsets across different disease states is an area of ongoing and intense investigation. Recent studies have identified metabolic reprogramming as a key mechanism underlying macrophage polarization. The current paradigm is that, broadly speaking, M1-like macrophages (which are typically monocyte-like) rely more on glycolysis to fuel pro-inflammatory functions, while M2-like macrophages rely more on mitochondrial oxidative phosphorylation to quell pro-inflammatory functions and fuel anti-inflammatory processes2. Understanding how macrophage metabolism is altered in different disease states can provide insight into potential therapies that could be used to target metabolic pathways.
As an example, our lab has extensively investigated the role of macrophage metabolic reprogramming during myocardial infarction (MI)3,4,5. Macrophages play a key role in the inflammatory and wound healing response during MI and, as such, undergo polarization from M1-like towards M2-like phenotypes as the infarcted heart undergoes remodeling to form replacement scar tissue. Using the methods described herein, we have demonstrated that this polarization is characterized by unique changes in glucose and glutamine metabolism, and mitochondrial function. We describe methods for extracting cardiac macrophages, as well as splenic macrophages and bone marrow monocytes, which can be combined with extracellular flux analysis to assess ex vivo metabolic flux in a single day. We hope the methods described offer a standardized approach for assessing immune cell metabolic phenotypes to enhance reproducibility across labs studying this important topic.
The methods below describe protocols for extracting macrophages and performing ex vivo analysis of metabolic flux from the infarcted heart following MI, the spleen, and the bone marrow (Figure 1). For the MI heart and spleen, the extraction method used is identical. All protocols involving mice were approved by the University of Mississippi Medical Center Institutional Animal Care and Use Committee (Protocol #1371, Mouton).
1. Extraction of macrophages from the infarcted heart and spleen
NOTE: Extraction of tissue macrophages uses a negative selection strategy to first remove neutrophils, which are labeled with Ly6G-microbeads, and then a positive selection strategy to obtain macrophages with CD11b-microbeads3,4,5,6. When performing this protocol, work quickly and keep the cells cold.
2. Extraction of monocytes from bone marrow
NOTE: Extraction of monocytes from the bone marrow uses a negative selection strategy in which non-monocytes, including lymphocytes, natural killer cells, dendritic cells, erythroid cells, and granulocytes (i.e., neutrophils), are immunomagnetically labeled and removed.
3. Preparation of cells for metabolic flux analysis
Typical cell numbers obtained from the different tissues depend on the size, age, and sex of the animal. For an adult male mouse (i.e., 16 weeks old, ~30 g), the spleen may yield 3.0-4.0 × 106 macrophages, while the bone marrow (two tibias and two femurs) typically yields 1.0-1.5 × 106 monocytes (Figure 2A). The infarcted heart typically yields high numbers as well, depending on the day post MI4,5...
Our method details the rapid extraction of macrophages from bone marrow, spleen, and the infarcted heart, which can then be used to perform downstream analyses such as extracellular metabolic flux analysis. The combination of these two methods is a powerful tool that can quantify metabolic changes in macrophages under different disease or injury states, or metabolic states such as exercise. While our method focused on bone marrow and splenic macrophages, other macrophage reservoirs can be used, such as the peritoneal com...
The authors have no conflicts of interest to declare.
We would like to acknowledge the funding that supported this work: NIH/NHBLI 166737, NIH R00 HL146888, NIH U54HL169191, NIH/NIGMS P20GM104357, and NIH/NIGMS P30GM149404 for this work.
Name | Company | Catalog Number | Comments |
Anti-CD11b Microbeads UltraPure, mouse | Miltenyi Biotec | 130-126-725 | |
Anti-Ly6G Microbeads UltraPure, mouse | Miltenyi Biotec | 130-120-337 | |
Collagenase type II | Worthington | NC9522060 | |
Dnase type I | MillPore Sigma | 11284932001 | |
GentleMACS Octo Dissociator | Miltenyi Biotec | 130-096-427 | |
GentleMACS C Tubes | Miltenyi Biotec | 130-093-237 | MACS cell dissociation tubes |
Hank balanced salt solution | Fisher Scientific | 14-025-076 | |
LS Magnetic Columns | Miltenyi Biotec | 130-042-401 | |
MACS MultiStand | Miltenyi Biotec | 130-042-303 | |
MS Magnetic Columns | Miltenyi Biotec | 130-042-201 | |
Monocyte Isolation Kit Bone Marrow, mouse | Miltenyi Biotec | 130-100-629 | includes 1 mL of monocyte biotin-antibody cocktail, 2 mL of anti-biotin microbeads, 1 mL of FcR blocking reagent |
OctoMACS Separator | Miltenyi Biotec | 130-042-108 | |
Pre-separation filters (30 µm) | Miltenyi Biotec | 130-041-407 | |
QuadroMACS Separator | Miltenyi Biotec | 130-091-051 | |
Red Blood Cell Lysis Solution (10x) | Miltenyi Biotec | 130-094-183 | |
Seahorse XFe96 Analyzer | Agilent | ||
Seahorse XFe96 FluxPak | Agilent | 103792-100 | 18 Pro sensor cartridges, 18 Pro Cell Cutlure Microplates, 1 bottle of Seahorse XF Calibrant Solution |
Seahorse XF Glycolysis Stress Test Kit | Agilent | 103020-100 | 6 single-use pouches, each with glucose, oligomycin, and 2-deoxy-D-glucose |
Seahorse XF Mitochondrial Stress Test Kit | Agilent | 103015-100 | 6 single-use pouches, each with oligomycin, FCCP, and rotenone/antimycin A |
Seahorse XF RPMI Medium, pH 7.4, 500 mL | Agilent | 103576-100 | no phenol red, bicarbonate, glucose, pyruvate, or glutamine |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved